Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

AMRX Stock Forecast, Price Targets, Chart, Dividends & Analysis

Amneal Pharmaceuticals Inc. logo

Amneal Pharmaceuticals Inc.

Sector: Healthcare   

Industry: Drug Manufacturers - Specialty & Generic

7.18
 
USD
  
0.01
  
(0.14%)
Previous close: 7.17  Open: 7.18  Bid: 6.91  Ask: 7.3
52 week range    
5.18   
   9.48
Mkt Cap: 2,222 M  Avg Vol (90 Days): 1,654,130
Last updated: Thursday 17th April 2025

Stock Rankings

45
MarketXLS Rank
27
Technical
63
Quality
How are these ranks calculated?
Metrics

Growth

Peers

StockDividendMarket Cap (B)PEPrice ($)
Financials

AMRX Income Statement

Annual
Invalid dateDec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23Dec-24
AccretionOnPreferredStock-375 M1 M438000.0
AccruedPreferredStockDividends168 M-149 M
AcquisitionExpense16 M9 M8 M700000.0
Amortization of intangibles-4 M-73 M1,383 M1,305 M1,167 M1,096 M890 M732 M
Basic EPS from continuing operations-2.740.620.07-0.86-0.48-0.38
Basic EPS total-0.07-2.740.620.07-0.86-0.48-0.38
Basic weighted shares outstanding127 M132 M147 M149 M151 M176 M309 M
Cost of sales-507 M-939 M1,147 M1,364 M1,325 M1,428 M1,573 M1,774 M
Depreciation-42 M-64 M63 M60 M61 M68 M66 M63 M
DepreciationAndAmortization-42 M-64 M63 M60 M61 M68 M66 M63 M
Diluted EPS total-0.16-2.740.610.07-0.86-0.48-0.38
Diluted normalized net income/share0.610.07-0.86-0.48-0.38
Diluted weighted shares outstanding136 M149 M152 M151 M176 M309 M
Fees-2 M
GainOnSaleOfSecurity-29 M-3 M
GainsLossOnDisposalOfDiscontinuedOperations7 M123000.0
GeneralAndAdministrativeExpense-17 M-18 M290 M327 M366 M400 M430 M476 M
Gross operating profit526 M716 M479 M628 M769 M785 M821 M1,020 M
ImpairmentOfCapitalAssets-4 M39 M47 M3 M710000.013 M31 M
Income before tax171 M-203 M-220 M-36 M31 M-248 M-40 M-55 M
Income restructuring and M&A56 M34 M2 M2 M1 M2 M2 M
Income taxes2 M-1 M383 M-104 M11 M7 M9 M19 M
Interest income-71 M-142 M-168 M-146 M-136 M-158 M-211 M-259 M
InterestExpenseNonOperating-1 M5 M146 M136 M158 M5 M5 M
InterestExpenseOperating2 M
MinorityInterests-2 M33 M242 M22 M-10 M125 M-35 M-43 M
MiscOtherSpecialCharges-3 M-19 M194 M3 M15 M18 M-33 M12 M
Net income from total operations169 M-22 M-362 M91 M11 M-130 M-84 M-117 M
NetIncomeCommonStockholders1 M-23 M-362 M91 M11 M-130 M-84 M-117 M
NetIncomeContinuousOperations169 M-22 M-362 M91 M11 M-255 M-49 M-74 M
NetIncomeDiscontinuousOperations7 M123000.0
NetIncomeFromOtherGainsLosses149 M
NetNonOperatingInterestIncomeExpense-70 M-142 M-168 M-146 M-136 M159 M-211 M-259 M
NonRecurringOperationExpense-9 M-20 M12 M6 M25 M270 M2 M97 M
Normalized income46 M
Operating income236 M56 M-249 M91 M153 M-95 M204 M249 M
Operating income before depreciation (EBITDA)221 M-47 M35 M346 M401 M-90 M205 M215 M
OperatingExpense290 M660 M475 M508 M562 M596 M592 M667 M
Other income net32 M22 M-194 M-3 M-15 M-278 M18 M-13 M
Other special charges-4 M-1 M
OtherGandA-17 M-18 M290 M327 M366 M400 M430 M476 M
OtherImpairmentOfCapitalAssets2 M1000000.024 M67 M920000.0
OtherOperatingExpenses16 M14 M11 M8 M398000.0-1 M-210000.0
OtherunderPreferredStockDividend168 M1 M438000.0
PreferredStockDividends168 M1 M438000.0
RentAndLandingFees-17 M-18 M
Research & development expense171 M194 M188 M180 M202 M196 M164 M191 M
ResearchExpense171 M194 M188 M180 M202 M196 M164 M191 M
RestructringAndMnAIncome56 M34 M2 M2 M1 M2 M2 M
Revenue per share-9 M-79 M1,389 M1,313 M1,172 M1,101 M895 M737 M
SalariesAndWages9 M222 M-16 M-9 M-13 M32 M27 M28 M
Selling Gen & administrative expense109 M228 M290 M327 M366 M400 M430 M476 M
SellingAndMarketingExpense109 M228 M
SellingExpense109 M228 M
Special income/charges9 M-76 M-93 M-11 M-28 M-284 M-34 M-99 M
Total Income available for interest expense (EBIT)170 M-201 M-216 M110 M168 M-90 M-36 M-50 M
Total common shares outstanding1000.0299 M299 M300 M302 M304 M307 M310 M
Total net income169 M-22 M-362 M91 M11 M-130 M-84 M-117 M
Total ordinary shares310 M310 M310 M310 M310 M310 M310 M310 M
Total revenues1,034 M1,655 M1,753 M2,027 M2,116 M2,212 M2,394 M2,794 M
TotalExpenses-218 M-279 M1,623 M1,838 M1,864 M2,023 M2,166 M2,441 M
TotalRevenue1,034 M1,663 M1,626 M1,993 M2,094 M2,212 M2,394 M2,794 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement "your own" investment strategies in Excel with thousands of MarketXLS functions and templates.
MarketXLS provides all the tools I need for in-depth stock analysis. It's user-friendly and constantly improving. A must-have for serious investors.

John D.

Financial Analyst

I have been using MarketXLS for the last 6+ years and they really enhanced the product every year and now in the journey of bringing in AI...

Kirubakaran K.

Investment Professional

MarketXLS is a powerful tool for financial modeling. It integrates seamlessly with Excel and provides real-time data.

David L.

Financial Analyst

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel.

Lloyd L.

Professional Trader